During 2018, Whispering Winds Tools Ltd.. a Canadian public company, purchased a building site for its product development laboratory at a cost of $66,600. Construction of the building started in 2018 . The building was completed in late December 2019 at a cost of $173,400 and placed in service on January 2, 2020. The building's estimated useful life for depreciation purposes is 15 years. The straight-line method of depreciation is used and there is no estimated residual value. After the building went into service, several projects were begun and many are still in process. Management estimates that about 50% of the development projects will result in long-term benefits (for at least 10 years) to the corporation. The other projects either benefited the current period or were abandoned before completion. A summary of the different projects, their number, and the direct costs that were incurred for development activities in 2020 appears in the table that follows. On the recommendation of its research and development group. Whispering Winds Tools Ltd. acquired a patent for manufacturing rights at a cost of $102,800. The patent was acquired on April 1,2019, and has an economic life of 10 years. How should the items above that relate to product development activities be reported under IFRS on the company's income statement and statement of financial position at December 31, 2020? For the statement of financial position, show buildings net of accoumulated depreciation and intangible assets net of accumulated amortization. (Enter negative amounts using either a negative sign preceding the number eg. -45 or parentheses es. (45). Round answers to 0 decimal ploces, es 5,275.)